Genetic heterogeneity in osteogenesis imperfecta.

D O Sillence, A Senn, D M Danks

An epidemiological and genetical study of osteogenesis imperfecta (OI) in Victoria, Australia confirmed that there are at least four distinct syndromes at present called OI. The largest group of patients showed autosomal dominant inheritance of osteoporosis leading to fractures and distinctly blue sclerae. A large proportion of adults had presenile deafness or a family history of presenile conductive hearing loss. A second group, who comprised the majority of newborns with neonatal fractures, all died before or soon after birth. These had characteristic broad, crumpled femora and beaded ribs in skeletal x-rays. Autosomal recessive inheritance was likely for some, if not all, of these cases. A third group, two thirds of whom had fractures at birth, showed severe progressive deformity of limbs and spine. The density of scleral blueness appeared less than that seen in the first group of patients and approximated that seen in normal children and adults. Moreover, the blueness appeared to decrease with age. All patients in this group were sporadic cases. The mode of inheritance was not resolved by the study, but it is likely that the group is heterogeneous with both dominant and recessive genotypes responsible for the syndrome. The fourth group of patients showed dominant inheritance of osteoporosis leading to fractures, with variable deformity of long bones, but normal sclerae.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Losa Iglesias, M. E., Becerro de Bengoa Vallejo, R., Salvadores Fuentes, P. (2009). In-toeing in Children with Type I Osteogenesis Imperfecta: An Observational Descriptive Study. J. Am. Podiatr. Med. Assoc. 99: 326-329 [Abstract] [Full Text]  
• Willaert, A, Malfait, F, Symoens, S, Gevaert, K, Kayserili, H, Megarbane, A, Mortier, G, Leroy, J G, Coucke, P J, De Paepe, A (2009). Recessive osteogenesis imperfecta caused by LEPRE1 mutations: clinical documentation and identification of the splice form responsible for prolyl 3-hydroxylation. J. Med. Genet. 46: 233-241 [Abstract] [Full Text]  
• Teixeira, C. S., Felippe, M. C. S., Felippe, W. T., Silva-Sousa, Y. T. C., Sousa-Neto, M. D. (2008). The Role of Dentists in Diagnosing Osteogenesis Imperfecta in Patients With Dentinogenesis Imperfecta. Journal of the American Dental Association 139: 906-914 [Abstract] [Full Text]  
• BRUSIN, J. H. (2008). Osteogenesis Imperfecta. radtech 79: 535-548 [Abstract] [Full Text]  
• Dighe, M., Fligner, C., Cheng, E., Warren, B., Dubinsky, T. (2008). Fetal Skeletal Dysplasia: An Approach to Diagnosis with Illustrative Cases1. RadioGraphics 28: 1061-1077 [Abstract] [Full Text]  
• Burnei, G., Vlad, C., Georgescu, I., Gavriliu, T. S., Dan, D. (2008). Osteogenesis Imperfecta: Diagnosis and Treatment. J Am Acad Orthop Surg 16: 356-366 [Abstract] [Full Text]  
• Semler, O., Fricke, O., Vezyroglou, K., Stark, C., Stabrey, A., Schoenau, E. (2008). Results of a prospective pilot trial on mobility after whole body vibration in children and adolescents with osteogenesis imperfecta. Clin Rehabil 22: 387-394 [Abstract]  
• Senthilnathan, S, Walker, E, Bishop, N J (2008). Two doses of pamidronate in infants with osteogenesis imperfecta. Arch. Dis. Child. 93: 398-400 [Abstract] [Full Text]  
• Fassier, A. M., Rauch, F., Aarabi, M., Janelle, C., Fassier, F. (2007). Radial Head Dislocation and Subluxation in Osteogenesis Imperfecta. JBJS 89: 2694-2704 [Abstract] [Full Text]  
• Chang, P.-C., Lin, S.-Y., Hsu, K.-H. (2007). The craniofacial characteristics of osteogenesis imperfecta patients. Eur J Orthod 29: 232-237 [Abstract] [Full Text]  
• Cundy, T., Horne, A., Bolland, M., Gamble, G., Davidson, J. (2007). Bone Formation Markers in Adults with Mild Osteogenesis Imperfecta. Clin. Chem. 53: 1109-1114 [Abstract] [Full Text]  
• Cho, T.-J., Choi, I. H., Chung, C. Y., Yoo, W. J., Lee, K. S., Lee, D. Y. (2007). Interlocking Telescopic Rod for Patients with Osteogenesis Imperfecta. JBJS 89: 1028-1035 [Abstract] [Full Text]  
• Barnes, A. M., Chang, W., Morello, R., Cabral, W. A., Weis, M., Eyre, D. R., Leikin, S., Makareeva, E., Kuznetsova, N., Uveges, T. E., Ashok, A., Flor, A. W., Mulvihill, J. J., Wilson, P. L., Sundaram, U. T., Lee, B., Marini, J. C. (2006). Deficiency of Cartilage-Associated Protein in Recessive Lethal Osteogenesis Imperfecta. NEJM 355: 2757-2764 [Abstract] [Full Text]  
• Cabral, W A, Milgrom, S, Letocha, A D, Moriarty, E, Marini, J C (2006). Biochemical screening of type I collagen in osteogenesis imperfecta: detection of glycine substitutions in the amino end of the alpha chains requires supplementation by molecular analysis.. J. Med. Genet. 43: 685-690 [Abstract] [Full Text]  
• Huang, R. P., Ambrose, C. G., Sullivan, E., Haynes, R. J. (2006). Functional Significance of Bone Density Measurements in Children with Osteogenesis Imperfecta. JBJS 88: 1324-1330 [Abstract] [Full Text]  
• Darmanis, S., Bircher, M. (2006). Fractures of the acetabulum in osteogenesis imperfecta. J Bone Joint Surg Br 88-B: 670-672 [Abstract] [Full Text]  
• Ward, L. M., Denker, A. E., Porras, A., Shugarts, S., Kline, W., Travers, R., Mao, C., Rauch, F., Maes, A., Larson, P., Deutsch, P., Glorieux, F. H. (2005). Single-Dose Pharmacokinetics and Tolerability of Alendronate 35- and 70-Milligram Tablets in Children and Adolescents with Osteogenesis Imperfecta Type I. J. Clin. Endocrinol. Metab. 90: 4051-4056 [Abstract] [Full Text]  
• Cabral, W. A., Makareeva, E., Colige, A., Letocha, A. D., Ty, J. M., Yeowell, H. N., Pals, G., Leikin, S., Marini, J. C. (2005). Mutations Near Amino End of {alpha}1(I) Collagen Cause Combined Osteogenesis Imperfecta/Ehlers-Danlos Syndrome by Interference with N-propeptide Processing. J. Biol. Chem. 280: 19259-19269 [Abstract] [Full Text]  
• Symoens, S, Nuytinck, L, Legius, E, Malfait, F, Coucke, P J, De Paepe, A (2004). Met>Val substitution in a highly conserved region of the pro-{alpha}1(I) collagen C-propeptide domain causes alternative splicing and a mild EDS/OI phenotype. J. Med. Genet. 41: e96-e96 [Full Text]  
• Alkadhi, H., Rissmann, D., Kollias, S. S. (2004). Osteogenesis Imperfecta of the Temporal Bone: CT and MR Imaging in Van der Hoeve-de Kleyn Syndrome. Am. J. Neuroradiol. 25: 1106-1109 [Abstract] [Full Text]  
• Seeliger, F., Leeb, T., Peters, M., Brugmann, M., Fehr, M., Hewicker-Trautwein, M. (2003). Osteogenesis Imperfecta in Two Litters of Dachshunds. Vet Pathol 40: 530-539 [Abstract] [Full Text]  
• Zeitlin, L., Rauch, F., Plotkin, H., Glorieux, F. H. (2003). Height and Weight Development During Four Years of Therapy With Cyclical Intravenous Pamidronate in Children and Adolescents With Osteogenesis Imperfecta Types I, III, and IV. Pediatrics 111: 1030-1036 [Abstract] [Full Text]  
• Montpetit, K., Plotkin, H., Rauch, F., Bilodeau, N., Cloutier, S., Rabzel, M., Glorieux, F. H. (2003). Rapid Increase in Grip Force After Start of Pamidronate Therapy in Children and Adolescents With Severe Osteogenesis Imperfecta. Pediatrics 111: e601-603 [Abstract] [Full Text]  
• Cabral, W. A., Mertts, M. V., Makareeva, E., Colige, A., Tekin, M., Pandya, A., Leikin, S., Marini, J. C. (2003). Type I Collagen Triplet Duplication Mutation in Lethal Osteogenesis Imperfecta Shifts Register of alpha Chains throughout the Helix and Disrupts Incorporation of Mutant Helices into Fibrils and Extracellular Matrix. J. Biol. Chem. 278: 10006-10012 [Abstract] [Full Text]  
• Rauch, F., Plotkin, H., Travers, R., Zeitlin, L., Glorieux, F. H. (2003). Osteogenesis Imperfecta Types I, III, and IV: Effect of Pamidronate Therapy on Bone and Mineral Metabolism. J. Clin. Endocrinol. Metab. 88: 986-992 [Abstract] [Full Text]  
• Falk, M. J., Heeger, S., Lynch, K. A., DeCaro, K. R., Bohach, D., Gibson, K. S., Warman, M. L. (2003). Intravenous Bisphosphonate Therapy in Children With Osteogenesis Imperfecta. Pediatrics 111: 573-578 [Abstract] [Full Text]  
• Millington-Ward, S., Allers, C., Tuohy, G., Conget, P., Allen, D., McMahon, H. P., Kenna, P. F., Humphries, P., Farrar, G. J. (2002). Validation in mesenchymal progenitor cells of a mutation-independent ex vivo approach to gene therapy for osteogenesis imperfecta. Hum Mol Genet 11: 2201-2206 [Abstract] [Full Text]  
• Hansen, B., Jemec, G. B. E. (2002). The Mechanical Properties of Skin in Osteogenesis Imperfecta. Arch Dermatol 138: 909-911 [Abstract] [Full Text]  
• Heimert, T. L., Lin, D. D. M., Yousem, D. M. (2002). Case 48: Osteogenesis Imperfecta of the Temporal Bone. Radiology 224: 166-170 [Full Text]  
• Marlowe, A, Pepin, M G, Byers, P H (2002). Testing for osteogenesis imperfecta in cases of suspected non-accidental injury. J. Med. Genet. 39: 382-386 [Abstract] [Full Text]  
• Kalajzic, I., Terzic, J., Rumboldt, Z., Mack, K., Naprta, A., Ledgard, F., Gronowicz, G., Clark, S. H., Rowe, D. W. (2002). Osteoblastic Response to the Defective Matrix in the Osteogenesis Imperfecta Murine (oim) Mouse. Endocrinology 143: 1594-1601 [Abstract] [Full Text]  
• Astrom, E, Soderhall, S (2002). Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch. Dis. Child. 86: 356-364 [Abstract] [Full Text]  
• Johnson, M T, Morrison, S, Heeger, S, Mooney, S, Byers, P H, Robin, N H (2002). A variant of osteogenesis imperfecta type IV with resolving kyphomelia is caused by a novel COL1A2 mutation. J. Med. Genet. 39: 128-132 [Full Text]  
• Pace, J M, Chitayat, D, Atkinson, M, Wilcox, W R, Schwarze, U, Byers, P H (2002). A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the pro{alpha}1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases. J. Med. Genet. 39: 23-29 [Abstract] [Full Text]  
• Shapiro, F. D., de Leval, L. (2000). Case 32-2000- A Boy with Vertebral Compression Fractures. NEJM 343: 1168-1176 [Full Text]  
• Dawson, P. A., Marini, J. C. (2000). Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts. Nucleic Acids Res 28: 4013-4020 [Abstract] [Full Text]  
• Plotkin, H., Rauch, F., Bishop, N. J., Montpetit, K., Ruck-Gibis, J., Travers, R., Glorieux, F. H. (2000). Pamidronate Treatment of Severe Osteogenesis Imperfecta in Children under 3 Years of Age. J. Clin. Endocrinol. Metab. 85: 1846-1850 [Abstract] [Full Text]  
• Nuytinck, L., Tükel, T., Kayserili, H., Apak, M. Y., De Paepe, A. (2000). Glycine to tryptophan substitution in type I collagen in a patient with OI type III: a unique collagen mutation. J. Med. Genet. 37: 371-375 [Abstract] [Full Text]  
• Deodhar, A. A, Woolf, A. D (2000). Fragile without fractures. Ann Rheum Dis 59: 166-171 [Full Text]  
• Moog, U, Maroteaux, P, Schrander-Stumpel, C T R M, van Ooij, A, Schrander, J J P, Fryns, J P (1999). Two sibs with an unusual pattern of skeletal malformations resembling osteogenesis imperfecta: a new type of skeletal dysplasia?. J. Med. Genet. 36: 856-858 [Abstract] [Full Text]  
• Lund, A. M, Müller, J., Skovby, F. (1999). Anthropometry of patients with osteogenesis imperfecta. Arch. Dis. Child. 80: 524-528 [Abstract] [Full Text]  
• Palmer, T. M., Rouse, G. A., Song, A., de Lange, M. (1998). Transparent Bone and Concave Ribs: Additional Sonographic Features of Lethal Osteogenesis Imperfecta. Journal of Diagnostic Medical Sonography 14: 246-250 [Abstract]  
• Glorieux, F. H., Bishop, N. J., Plotkin, H., Chabot, G., Lanoue, G., Travers, R. (1998). Cyclic Administration of Pamidronate in Children with Severe Osteogenesis Imperfecta. NEJM 339: 947-952 [Abstract] [Full Text]  
• Marini, J. C. (1998). Osteogenesis Imperfecta -- Managing Brittle Bones. NEJM 339: 986-987 [Full Text]  
• Marini, J. C., Gerber, N. L. (1997). Osteogenesis Imperfecta: Rehabilitation and Prospects for Gene Therapy. JAMA 277: 746-750 [Abstract]  
• Engelbert, R. H. H., van der Graaf, Y., van Empelen, R., Beemer, F. A., Helders, P. J. M. (1997). Osteogenesis Imperfecta in Childhood: Impairment and Disability. Pediatrics 99: e3-e3 [Abstract] [Full Text]  
• Williams, C J C, Smith, R A, Ball, R J, Wilkinson, H (1997). Hypercalcaemia in osteogenesis imperfecta treated with pamidronate. Arch. Dis. Child. 76: 169-170 [Abstract] [Full Text]  
• Wang, Q., Forlino, A., Marini, J. C. (1996). Alternative Splicing in COL1A1 mRNA Leads to a Partial Null Allele and Two In-frame Forms with Structural Defects in Non-lethal Osteogenesis Imperfecta. J. Biol. Chem. 271: 28617-28623 [Abstract] [Full Text]  
• Mundlos, S., Chan, D., Weng, Y. M., Sillence, D. O., Cole, W. G., Bateman, J. F. (1996). Multiexon Deletions in the Type I Collagen COL1A2 Gene in Osteogenesis Imperfecta Type IB. MOLECULES CONTAINING THE SHORTENED alpha 2(I) CHAINS SHOW DIFFERENTIAL INCORPORATION INTO THE BONE AND SKIN EXTRACELLULAR MATRIX. J. Biol. Chem. 271: 21068-21074 [Abstract] [Full Text]  
• ISHIKAWA, S., KUMAR, S. J., TAKAHASHI, H. E., HOMMA, M. (1996). Vertebral Body Shape as a Predictor of Spinal Deformity in Osteogenesis Imperfecta. JBJS 78: 212-9 [Abstract] [Full Text]  
• RING, D., JUPITER, J. B., LABROPOULOS, P. K., GUGGENHEIM, J. J., STANITSKY, D. F., SPENCER, D. M. (1996). Treatment of Deformity of the Lower Limb in Adults Who Have Osteogenesis Imperfecta. JBJS 78: 220-5 [Abstract] [Full Text]  
• Lamandé, S. R., Chessler, S. D., Golub, S. B., Byers, P. H., Chan, D., Cole, W. G., Sillence, D. O., Bateman, J. F. (1995). Endoplasmic Reticulum-mediated Quality Control of Type I Collagen Production by Cells from Osteogenesis Imperfecta Patients with Mutations in the pro[IMAGE]1(I) Chain Carboxyl-terminal Propeptide which Impair Subunit Assembly. J. Biol. Chem. 270: 8642-8649 [Abstract] [Full Text]  
• Garretsen, T. J. T. M., Cremers, W. R. J. (1990). Ear Surgery in Osteogenesis Imperfecta: Clinical Findings and Short-term and Long-term Results. Arch Otolaryngol Head Neck Surg 116: 317-323 [Abstract]  
• Cardenas, N., Manrique, T. A., Catlin, E. A. (1988). Flail Chest in the Newborn: A Complication of Osteogenesis Imperfecta. CLIN PEDIATR 27: 161-162  
• Bornemann, M., Saxon, J. R., Kidd, G. S. II (1987). Osteoporosis Unmasked by Hyperthyroidism in a Young Man With Osteogenesis Imperfecta. Arch Intern Med 147: 1947-1948 [Abstract]  
• UITTO, J., MURRAY, L. W., BLUMBERG, B., SHAMBAN, A. (1986). Biochemistry of Collagen in Diseases. ANN INTERN MED 105: 740-756 [Abstract]  
• Tsipouras, P., Barabas, G., Matthews, W. S. (1986). Neurologic Correlates of Osteogenesis Imperfecta. Arch Neurol 43: 150-152 [Abstract]  
• Shapiro, J. R., Triche, T., Rowe, D. W., Munabi, A., Cattell, H. S. (1983). Osteogenesis Imperfecta and Paget's Disease of Bone: Biochemical and Morphologic Studies. Arch Intern Med 143: 2250-2257 [Abstract]  
• SHAPIRO, J. R., ROWE, D. W. (1983). Collagen Genes and Brittle Bones. ANN INTERN MED 99: 700-704 [Abstract]  
• Riedner, E. D., Levin, L. S., Holliday, M. J. (1980). Hearing Patterns in Dominant Osteogenesis Imperfecta. Arch Otolaryngol Head Neck Surg 106: 737-740 [Abstract]  
• Beck, K., Chan, V. C., Shenoy, N., Kirkpatrick, A., Ramshaw, J. A. M., Brodsky, B. (2000). Destabilization of osteogenesis imperfecta collagen-like model peptides correlates with the identity of the residue replacing glycine. Proc. Natl. Acad. Sci. USA 97: 4273-4278 [Abstract] [Full Text]